Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Trastuzumab × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 101 Stomach Neoplasms 17 HER2-positive Breast Cancer 13 Neoplasms 11 Neoplasm Metastasis 9 Colorectal Neoplasms 9 Esophageal Neoplasms 7 Triple Negative Breast Neoplasms 4 Meningeal Neoplasms 4 Colonic Neoplasms 4 Brain Neoplasms 4 Adenocarcinoma Of Esophagus 4 Salivary Gland Neoplasms 3 Rectal Neoplasms 3 Meningeal Carcinomatosis 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3 Gallbladder Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Biliary Tract Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Solid Tumors 2 Prostatic Neoplasms 2 Pathologic Complete Response 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Inflammatory Breast Neoplasms 2 Hematologic Neoplasms 2 HER2-positive Gastric Cancer 2

Interventions

Nivolumab 63 pembrolizumab 62 cabozantinib 43 Ipilimumab 33 Magnetic Resonance Spectroscopy 30 Specimen Handling 26 lenvatinib 21 Axitinib 20 belzutifan 16 Sunitinib 16 Radiosurgery 13 Biopsy 13 atezolizumab 10 Everolimus 10 CTLA-4 Antigen 10 pazopanib 9 avelumab 8 Radiotherapy 8 Bevacizumab 8 fludarabine 6 cemiplimab 6 aldesleukin 6 Standard of Care 6 Nephrectomy 6 Immunoglobulin G 6 Cyclophosphamide 6 toripalimab 5 spartalizumab 5 Paclitaxel 5 tivozanib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡